| $385M | ||
| $337M | ||
| $100M | ||
| $87M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung diseases resulting from bacterial infections; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; Zylö Therapeutics, Inc., and the University of Cincinnati. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.
Over the last 12 months, insiders at Hoth Therapeutics, Inc. have bought $0 and sold $0 worth of Hoth Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Hoth Therapeutics, Inc. have bought $16,750 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $16,750 was made by Knie Robb (CEO and President) on 2024‑08‑16.
| 2024-08-16 | Knie Robb | CEO and President | 25,000 0.5041% | $0.67 | $16,750 | +32.10% | ||
| 2020-05-26 | Sale | Hayes Anthony | 0 – | $0 | $0 | -25.09% |
| Knie Robb | CEO and President | 58131 0.4384% | $69,757.20 | 1 | 0 | +32.1% |
| Hayes Anthony | 0 0% | $0 | 0 | 1 |
$53,490,060 | 55 | 19.35% | $14.87M | |
$17,168,388 | 54 | -43.55% | $13.86M | |
$555,628 | 21 | 43.52% | $16.89M | |
$1,616,354 | 20 | -12.22% | $18.43M | |
$53,355 | 19 | -41.05% | $14.1M | |
$613,181 | 18 | -20.90% | $15.75M | |
$112,810,270 | 18 | -1.20% | $14.25M | |
$25,487,383 | 15 | -4.37% | $17.45M | |
$112,908,886 | 15 | -2.59% | $15.58M | |
$4,146,041 | 11 | -40.86% | $15.26M | |
$11,777,042 | 10 | -11.94% | $13.19M | |
$147,504 | 5 | -36.70% | $21.13M | |
$87,925 | 5 | -18.56% | $19.19M | |
$1,184,658 | 4 | -22.17% | $14.9M | |
$14,530 | 3 | 62.23% | $16.23M | |
Hoth Therapeutics, Inc. (HOTH) | $16,750 | 1 | 32.10% | $15.91M |
$3,750 | 1 | -33.13% | $18.46M | |
$500,000 | 1 | -22.94% | $16.95M | |
$30,190 | 1 | -42.39% | $17.38M |
| Increased Positions | 20 | +166.67% | 1M | +417.72% |
| Decreased Positions | 4 | -33.33% | 35,905 | -13.55% |
| New Positions | 13 | New | 830,861 | New |
| Sold Out Positions | 2 | Sold Out | 30,000 | Sold Out |
| Total Postitions | 28 | +133.33% | 1M | +404.17% |
| Renaissance Technologies Llc | $295.00 | 1.53% | 243,921 | +243,921 | New | 2025-09-30 |
| Vanguard Group Inc | $259.00 | 1.34% | 214,009 | +175,205 | +451.51% | 2025-09-30 |
| Geode Capital Management, Llc | $186.00 | 0.96% | 153,535 | +30,960 | +25.26% | 2025-09-30 |
| Citadel Advisors Llc | $174.00 | 0.9% | 143,473 | +143,473 | New | 2025-09-30 |
| Virtu Financial Llc | $137.00 | 0.71% | 113,412 | +113,412 | New | 2025-09-30 |
| Ubs Group Ag | $115.00 | 0.59% | 94,665 | +52,425 | +124.11% | 2025-09-30 |
| Hrt Financial Lp | $103.00 | 0.53% | 85,332 | +85,332 | New | 2025-09-30 |
| State Street Corp | $77.00 | 0.4% | 63,939 | +63,939 | New | 2025-09-30 |
| Jane Street Group, Llc | $66.00 | 0.34% | 54,940 | +54,940 | New | 2025-09-30 |
| Northern Trust Corp | $50.00 | 0.26% | 41,504 | +41,504 | New | 2025-09-30 |